Member Info for EyeGuy

I think it’s more to do with this being CE marked and being certified as a class 1 medical device.
I think it’s due to it being a development of CADRON so I guess if someone wanted to copy it, it would take a while to get the certifications. At which point hopefully nhs has signed up bleepa on rolling contracts

Also perfect build time for aim. Circa 5 weeks until the event gives plenty of time for this sp to shift. Blue sky potential. If they get the NHS on board then who knows how high this is going. No alternative too. Happy to see how this plays out. Can see another 30% tomorrow too

Will hold this through August.

certainly is. Can you imagine how much the NHS could get fined if patients complained that their data was being shared on WhatsApp and sent abroad?

key is the software is already used by the NHS, and there is not another product that offers this. Also 97% of practioners are using WhatsApp which is not a safe thing to do.

mms short now imo. Looking forward to this afternoon. Exciting tech here.

MED_IS Maybe shares aren't for you pal. NCCL- I have been here at 1p when folks were saying placing at 0.5p.
You cant blame others for your trading strategy not working out on the news. I thought it would be higher. Of course.

@med_is: EVG is one of my picks for 2019. Cant blame me for anything pal. Its a good share

nice one Scott. !!!

NHS imo need this and CADRAN tech already working. Could be multiples

I took a small quantity on Friday at circa 1.50p. Looks good. These companies can do anything and I think it will keep going up to September. Watched the proactive over the weekend and looked at the Bleepa twitter feeds. First mover advantage

Yep. It’s almost like a junior jlp in the making. Missed by market. Look on twitter. Hardly anyone tweeting about it. Folks unaware

Morning all. Should be in for a strong few weeks. Once the JLP confirm sable takeover then its game on.

should be a good run up anyway. very much under the radar

also maybe some vanadium credits

yep. aware of that already. cheers though

Good post TbyT. I have taken some too. Mixed with CB at the helm. Did hold JLP for a while.
Certainly $10 million annual cashflows not priced in at this mcap and I agree that if this commanded an mcap of £15 million then no one would bat an eyelid. Plenty of upside, but aware too of the risks. Risk vs reward very favourable

Sell now cleared

Sell probably. Looks primed now for a rise

for balance I did hold JLP for years. Not now. There are no future revenues priced in here.